Defined as treatment of disabilities/illnesses (physical and mental), therapy represents an essential branch of medicine. This term is widely used by psychologists to describe the session between them and patients. Depending on an illness, different therapies types are applied. Therapies may be aimed at the prevention of the disease occurrence, stopping its further progress or preventing an outbreak. They may be also used to improve a patient’s comfort.
Therapies are classified on the basis of energy (e.g. phototherapy and thermotherapy), human interaction (for instance, psychotherapy and psychotherapy) and matter (e.g. gene therapy and biotherapy), etc.
The Catalogue is an unprecedented source of research reports analyzing the therapy market in detail. The reports uncover the market sizing and segmentation, its present standing and future prospects. The research studies investigate the competitive environment and contain majors’ profiles. Market igniters and limiters are scrutinized, and trends and future opportunities are unveiled in the reports.
Publications found:
1,146
Sort by:
Hot and Cold Therapy Packs: Market Research Report
US$ 5,450.00
This report analyzes the worldwide markets for Hot and Cold Therapy Packs in US$ by the following Product Segments: Cold Packs, Hot Packs, Moist Therapy Packs, and Localized Heating/Cooling Pads. The ...
March 2018
249 pages
Global Brachytherapy Therapy Market 2018-2024
US$ 2,750.00
Global Brachytherapy Devices Market – Drivers, Opportunities, Trends, and Forecasts: 2018–2024 Overview: Brachytherapy is a medical procedure popularly referred to as radiation therapy. It is used to treat various types of cancers which involves ...
March 2018
99 pages
Pseudomonas aeruginosa Infections - Pipeline Review, H1 2018
US$ 2,000.00
... . The Pseudomonas aeruginosa Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Pseudomonas aeruginosa Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2018
260 pages
Cell Therapy Processing: Global Markets and Technologies
US$ 1,250.00
... in-depth analysis of the global cell therapy processing market by offering type, application and geographic regional markets. The report includes key inhibitors ... in the global cell therapy processing market. In-depth patent analysis in the report will provide extensive technological trends across years ...
March 2018
187 pages
Hemophilia B - Pipeline Review, H1 2018
US$ 2,000.00
... releases. The Hemophilia B (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Hemophilia B and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2018
126 pages
Choroidal Neovascularization - Pipeline Review, H1 2018
US$ 2,000.00
... releases. The Choroidal Neovascularization (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Choroidal Neovascularization and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2018
47 pages
Interstitial Cystitis (Painful Bladder Syndrome) - Pipeline Review, H1 2018
US$ 2,000.00
... Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Interstitial Cystitis (Painful Bladder Syndrome) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2018
90 pages
Cedar Pollen Allergy - Pipeline Review, H1 2018
US$ 2,000.00
... releases. The Cedar Pollen Allergy (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Cedar Pollen Allergy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2018
36 pages
Bronchitis - Pipeline Review, H1 2018
US$ 2,000.00
... releases. The Bronchitis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Bronchitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2018
68 pages
Ependymoma - Pipeline Review, H1 2018
US$ 2,000.00
... releases. The Ependymoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Ependymoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2018
149 pages
West Nile Virus Infections - Pipeline Review, H1 2018
US$ 2,000.00
... . The West Nile Virus Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for West Nile Virus Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2018
67 pages
Pseudomonas aeruginosa Pneumonia - Pipeline Review, H1 2018
US$ 2,000.00
... . The Pseudomonas aeruginosa Pneumonia (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Pseudomonas aeruginosa Pneumonia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2018
36 pages
Atopic Dermatitis - Pipeline Review, H1 2018
US$ 2,000.00
... releases. The Atopic Dermatitis (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Atopic Dermatitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
February 2018
379 pages
Scar - Pipeline Review, H1 2018
US$ 2,000.00
... releases. The Scar (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Scar and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
February 2018
84 pages
Alpha- Antitrypsin Deficiency - Pipeline Review, H1 2018
US$ 2,000.00
... . The Alpha%li%Antitrypsin Deficiency (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Alpha%li%Antitrypsin Deficiency and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
February 2018
84 pages
